Error: Could not add to watchlist. X
+ Watchlist

Simcere Pharmaceutical Group

SCR:US
Acquired
SCR:US was acquired by 0860324D:CH
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CNY) (TTM)
3.32
Market Cap (USD)
-
Shares Outstanding (m)
51.282
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Generic Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
Address
699-18 Xuan Wu Avenue
Nanjing, 210 042
China
Phone
86-25-8556-6666
Show More